ArticleFrontiers in immunology2026

Complement inhibition by sutimlimab in cold agglutinin disease promotes red blood cell agglutination and may lead to circulatory complications, eryptosis and hemolysis.

Thilo Bartolmäs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.